Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,584.42
(
0.27%
)
US TECH 100
29,530.80
(
0.36%
)
Dow Jones
50,971.04
(
0.60%
)
Brent Oil
91.21
(
-1.06%
)
Bitcoin
73,507.97
(
-0.04%
)
News Focus
News Focus
Post# of 257657
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 123037
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 221784

Monday, 12/21/2020 8:33:04 AM

Monday, December 21, 2020 8:33:04 AM

Post# of 257657
(REGN)—Roche’s_Faricimab_dosed_q8w_shows_NI_to_Eylea_in DME:

https://www.roche.com/investors/updates/inv-update-2020-12-21.htm

Faricimab is a bi-specific mAb that targets VEGF-A and Ang-2.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Unleash the power of Level 2

Spot liquidity moves with access to US order books.

Sign Up